Alison Moskowitz Selected Research

Alison Moskowitz Research Topics

7	Lymphoma (Lymphomas) 01/2022 - 05/2016
5	Neoplasms (Cancer) 01/2023 - 01/2018
5	Mycosis Fungoides 01/2018 - 09/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 09/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2013
3	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021 - 01/2018
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 02/2014
2	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 11/2013
2	Exanthema (Rash) 01/2022 - 01/2018
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2020 - 01/2018
1	Osteonecrosis (Kienbock's Disease) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2022
1	Hyperglycemia 01/2022
1	Dermatitis 01/2022
1	Diarrhea 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Pruritus (Itching) 01/2022
1	Infections 01/2021
1	Symptom Flare Up 01/2021
1	COVID-19 01/2021
1	Extranodal NK-T-Cell Lymphoma 12/2020
1	Genetic Translocation (Chromosomal Translocation) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2018
1	Neutropenia 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2018
1	Disease Progression 09/2013
1	Confusion (Bewilderment) 09/2013

3	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 12/2020
3	Monoclonal AntibodiesIBA 12/2022 - 10/2018
2	pembrolizumabIBA 10/2023 - 01/2023
2	Bendamustine Hydrochloride FDA Link 12/2022 - 11/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	ParaffinIBA 12/2018 - 10/2018
2	Formaldehyde (Formol)FDA Link 12/2018 - 10/2018
1	cc-486IBA 01/2023
1	ofatumumab FDA Link 12/2022
1	ibrutinibIBA 01/2022
1	NVP-BKM120IBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	mogamulizumabIBA 01/2021
1	Vorinostat FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Ifosfamide FDA LinkGeneric 12/2020
1	Etoposide (VP 16)FDA LinkGeneric 12/2020
1	Asparaginase (Elspar)FDA Link 12/2020
1	Histone Deacetylase InhibitorsIBA 10/2020
1	RNA (Ribonucleic Acid)IBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Heme (Haem)IBA 12/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	duvelisibIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Glia Maturation Factor (GMF)IBA 09/2013

14	Therapeutics 01/2023 - 09/2013
4	Drug Therapy (Chemotherapy) 01/2021 - 09/2013
2	Radiotherapy 01/2018 - 09/2013
1	Immunotherapy 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2020
1	Autologous Transplantation 05/2019
1	Cell Transplantation 05/2019
1	Transplantation 05/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018